A5007225934- Diverticular Disease and Complications
- Liver Diseases and Immunity
- Eosinophilic Esophagitis
- Colorectal Cancer Surgical Treatments
- Drug-Induced Hepatotoxicity and Protection
- Hepatitis Viruses Studies and Epidemiology
- Foreign Body Medical Cases
- Esophageal and GI Pathology
- Liver Disease Diagnosis and Treatment
- Heart Failure Treatment and Management
- Colorectal and Anal Carcinomas
- Gastrointestinal Bleeding Diagnosis and Treatment
- Clostridium difficile and Clostridium perfringens research
- Cardiovascular and exercise physiology
- Cardiac Health and Mental Health
- Gastrointestinal disorders and treatments
- Iron Metabolism and Disorders
- Blood Pressure and Hypertension Studies
- Helicobacter pylori-related gastroenterology studies
- Drug Transport and Resistance Mechanisms
- Hemoglobinopathies and Related Disorders
- Gastrointestinal Tumor Research and Treatment
- Pleural and Pulmonary Diseases
- Intraperitoneal and Appendiceal Malignancies
- Curcumin's Biomedical Applications
Donostia Unibertsitate Ospitalea
2024
Biogipuzkoa Health Research Institute
2018-2023
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
2018-2021
University of the Basque Country
2018-2021
GTx (United States)
2019
Universidad de Zaragoza
2017
Antibiotic resistance is the main cause for Helicobacter pylori therapy failure. Frequently, empirical regimens have been recommended in patients with various H. eradication failures. In pylori-resistant to families of antibiotics, treatment guided by antimicrobial susceptibility testing allows achievement good rates.To evaluate effectiveness susceptibility-guided infection one or antibiotics.A total 3170 consecutive infected during 2013-2017 were tested susceptibility. 66.6% showed...
This study aims to assess the efficacy of hormone therapy in patients with severe gastrointestinal bleeding due multiple angiodysplastic lesions.Between May 2010 and July 2017, we included 12 consecutive anaemia or recurrent angiodysplasia who had been started on therapy. The given was a combination levonorgestrel (between 0.10 0.25 mg) ethinylestradiol 0.02 0.05 mg). We determined mean number transfusions required 6 months before after start treatment, as well haemoglobin levels, admissions...
Patients with chronic hepatitis C are at increased risk for hyperferritinemia (HF). Abnormalities of serum iron parameters frequently observed in patients (CHC). About a third have parameters. Recently, studies on the effect direct-acting antiviral agents (DAAs) HCV eradication has been published, demonstrating restoration normal status. The aim this study was to evaluate viral DDAs CHC and HF.Retrospective conducted from January 2018 December 2020 including treated DAAs HCV. Pre-treatment...